DocDollars

Redhill Biopharma Inc.

NC · United States · Reporting entity ID 100000751811

Total reported 2019–2025
$5.52M
#674 of 2,960 reporting companies — 0% of all reported industry payments
$3.73M in general payments across 56,450 records, plus $1.78M in research funding across 298 records.

How it breaks down

General payments $3,734,596
Research funding $1,783,527

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Redhill Biopharma Inc. reported $5.52M to US doctors and teaching hospitals from 2019 to 2025, ranking #674 of 2,960 reporting companies. 32% of that was research funding and 68% general payments such as consulting, speaking, food and travel. 56,450 general payment records and 298 research records were filed.

Common questions about Redhill Biopharma Inc.

How much has Redhill Biopharma Inc. paid US doctors?

Redhill Biopharma Inc. reported $5,518,123 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,734,596 in general payments, $1,783,527 in research funding.

How does Redhill Biopharma Inc. rank among drug and device companies?

It ranks #674 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Redhill Biopharma Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.